Which stock has a news catalyst is at an all time low

**Catalyst Pharmaceuticals (CPRX) is experiencing a news catalyst and is currently at an all-time low.**

1. **Recent Earnings Report**: Catalyst Pharmaceuticals is scheduled to report its third-quarter 2023 results on Nov 8, after market close. This upcoming earnings report could serve as a catalyst for the stock price, as it provides an opportunity for investors to assess the company's performance and outlook.
2. **Stock Performance**: The stock has been under pressure, with shares down by 31% in the last 30 days and a significant crash of 19% on May 10. This recent decline can be attributed to the company's Q1 performance, which although impressive with a 98% year-over-year revenue increase and a 117% increase in earnings per share, still fell short of analysts' expectations.
3. **Market Sentiment**: The stock's underperformance compared to expectations has led to a negative sentiment, despite the company's positive earnings surprise history and its growth prospects for 2023. This sentiment could be contributing to the stock's current all-time low.
4. **Financial Health**: It's important to note that Catalyst has a diversified portfolio with the addition of a commercial-stage epilepsy asset, Fycompa, and an exclusive license for vamorolone for Duchenne muscular dystrophy. These developments could provide a foundation for future growth, which may be reflected in the company's Q3 earnings report.
5. **Investor Consideration**: Given the mixed performance in previous quarters and the recent decline in stock price, investors should carefully consider the company's financial health and the potential risks and rewards of investing in Catalyst Pharmaceuticals at this time.